Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
The RAPS store will be under maintenance 15 January 2022 from 5 AM to 1 PM EST. Store functionality may be unavailable during this window.
We apologize for any inconvenience caused during this time.
Posted 11 September 2017 | By Zachary Brennan
The US Food and Drug Administration's (FDA) Center for Devices and Radiological Health (CDRH) will lead a pilot program to define characteristics of a device that are critical to product quality and how these characteristics are controlled in design and manufacturing prior to the postmarket inspection.
The voluntary pilot, which will run from 29 September to 31 December 2018, invites firms submitting a Premarket Approval Application (PMA) to consider participating in the Premarket Approval Application Critical to Quality (PMA CtQ) Pilot Program.
"The goal of this voluntary pilot—a part of CDRH's Case for Quality—is to streamline the premarket approval process while assuring that a firm's quality system includes rigorous controls for characteristics considered critical to the safety and effectiveness of the medical device," FDA said.
Nine PMA applicants will participate in the pilot and FDA said that for those participants, the agency would forego conducting the standard PMA preapproval inspection, but instead conduct a postmarket inspection focusing on the PMA applicant's implementation of the critical to quality characteristics.
Federal Register Notice
Tags: Critical to Quality, FDA pilot program
Regulatory Focus newsletters
All the biggest regulatory news and happenings.